Literature DB >> 12407135

Linezolid penetration into osteo-articular tissues.

B Rana1, I Butcher, P Grigoris, C Murnaghan, R A Seaton, C M Tobin.   

Abstract

Penetration of linezolid into osteo-articular tissue and fluid was studied in 10 patients undergoing primary total knee replacement. Linezolid 600 mg 12 hourly was given orally over the 48 h before operation and intravenously 1 h before induction of anaesthesia. Mean concentrations of linezolid at 90 min after the final dose, in serum, synovial fluid, synovium, muscle and cancellous bone, assayed by HPLC, were at least twice the MIC(90) for staphylococci and streptococci. The concentrations obtained indicate good penetration of this antibiotic and support its use in the management of multidrug-resistant Gram-positive bone, joint and deep-seated soft-tissue infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407135     DOI: 10.1093/jac/dkf207

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

1.  Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.

Authors:  Cornelia Buerger; Nele Plock; Pejman Dehghanyar; Christian Joukhadar; Charlotte Kloft
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Deletion of One 23S rRNA Gene (rrl) Copy Contributes to the Development of Linezolid Resistance in Staphylococcus warneri.

Authors:  Caroline Rouard; Florence Doucet-Populaire; Christelle Guillet-Caruba; Millie Villet; Nadège Bourgeois-Nicolaos
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

3.  Distribution of Linezolid in Tuberculosis Lesions in Patients with Spinal Multidrug-Resistant Tuberculosis.

Authors:  Yuan Li; Weijie Dong; Tinglong Lan; Jun Fan; Shibing Qin; Ai Guo
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

4.  [Influence of patellofemoral osteoarthritis on functional outcome after unicondylar knee arthroplasty].

Authors:  S M Hauptmann; U Kreul; F Mazoochian; C V Schulze-Pellengahr; V Jansson; P E Müller
Journal:  Orthopade       Date:  2005-11       Impact factor: 1.087

5.  Penetration of daptomycin into bone and synovial fluid in joint replacement.

Authors:  D Montange; F Berthier; G Leclerc; A Serre; L Jeunet; M Berard; P Muret; L Vettoretti; J Leroy; B Hoen; C Chirouze
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 6.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 7.  Clinical management of septic arthritis.

Authors:  Katie A Sharff; Eric P Richards; John M Townes
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

8.  Linezolid Treatment for Osteomyelitis due to Staphylococcus Epidermidis with Reduced Vancomycin Susceptibility.

Authors:  Joon Rok Nam; Myoung Soo Kim; Chae Heuck Lee; Dong Hee Whang
Journal:  J Korean Neurosurg Soc       Date:  2008-06-20

Review 9.  Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.

Authors:  Matthew E Falagas; Konstantinos Z Vardakas
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci.

Authors:  Friedrich Kutscha-Lissberg; Ute Hebler; Gert Muhr; Manfred Köller
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.